Ginkgo Results Presentation Deck

Platforms are dependent on customers bringing products to market Ginkgo has more than doubled the number of products in scale production by our customers so far this year in diverse fields... Product Ginkgo organism? Ginkgo process? Approx. Year Started Year Completed Customer Primary End Market Organism Product Type Mfg Scale (L) Downstream Economics Peach ✓ ✓ 2014 2019 03% ROBERTET Consumer Fungal (Species 1) Small Molecule Coconut [Confidential] Royalty/Toll ✓ 2016 2019 ROBERTET Consumer Fungal (Species 2) Small Molecule ✓ Royalty/Toll ✓ 2016 2018 (mig began in 2020) [Confidential] Chemicals Bacterial (Species 3) Small Molecule VCE Royalty/Toll ✓ ✓ 2020 2021 Caldevron Pharma Bacterial (Species 4) Protein Myoglobin Royalty ✓ ✓ 2018 2021 moti Food Fungal (Species 5) Protein Equity CBG Note: "Ginkgo organism" refers to a strain engineered by Ginkgo, whereas "Ginkgo process" refers to a manufacturing process developed by Ginkgo ✓ ✓ 2018 2021 CRONOS GROUP Consumer Fungal (Species 6) Small Molecule [Confidential] Milestone ✓ Most being produced in tanks at the 25,000 - 50,000L scale; some pharma products produced at lower scale (hundreds to 1.000L) 2020 2021 [Confidential] Pharma Bacterial (Species 4) Nucleic Acid N/A Fee for service CBGV ✓ ✓ 2018 2021 CRONOS GROUP Consumer Fungal (Species 6) Small Molecule Pilot Scale Milestone Property of Ginkgo Bioworks - 28 Q3 UPDATE & BUSINESS REVIEW Excerpt from Q3 2021 Earnings Call We must continue to drive a diverse set of programs to completion... ...and then rely on our customers to successfully bring those products to market 26 Property of Ginkgo Bioworks 2021 UPDATE & BUSINESS REVIEW

View entire presentation